Abdominal aortic aneurysm (AAA) is a ballooning of the aorta, the largest blood vessel in the human body, which extends into the abdomen. If the wall of this blood vessel becomes weakened, it can stretch, "balloon" out and rupture. A rupture, if left untreated, can lead to life-threatening internal bleeding. The exact cause of this condition is unknown. However, it often occurs in older adults, especially males, those with a high cholesterol level, and in smokers. There also tends to be a genetic link to this disorder.
Medtronic Inc. today announced the CE mark and international launch of the Endurant II AAA Stent Graft System, which meaningfully expands the options physicians outside the United States have to treat patients with abdominal aortic aneurysms through a minimally invasive technique called endovascular aortic repair.
TriVascular, Inc. of Santa Rosa, California, announced today the first Canadian patients treated with its Ovation Abdominal Stent Graft. The innovative, ultra low profile (14F OD) system is designed to expand the patient population suitable for endovascular aortic repair (EVAR) by addressing a wider range of diseased anatomy.
Researchers from Southwestern Texas University's Division of Vascular and Endovascular Surgery and the Veterans Medical Center, both in Dallas, have reported that composite surgeon (overall) volume rather than operation-specific (annual) surgeon volume is a key determinant of in-hospital mortality for elective open abdominal aortic aneurysm surgery.
The U.S. Food and Drug Administration today allowed marketing of the first system that can repair a failed or problematic aortic endograft, a fabric tube used to repair a dangerously large aortic aneurysm, a bulge in the large blood vessel that carries blood away from the heart.
Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Aptus EndoStapling System, which will now be known as the HeliFX™ Aortic Securement System.
Experts from the Cardiac & Vascular Institute at NYU Langone Medical Center presented new research findings at the American Heart Association Scientific Sessions 2011 held November 12-16, 2011 in Orlando, Florida.
W. L. Gore & Associates, Inc. (Gore) announced that it has received approval from the US Food and Drug Administration (FDA) to market the Conformable GORE TAG Thoracic Endoprosthesis as a minimally invasive treatment for patients suffering from thoracic aortic aneurysms.
Medical scientists have for the first time identified a gene responsible for a fatal abdominal condition that afflicts tens of thousands of people across the world.
The U.S. Food and Drug Administration has approved a stent graft system that provides patients with small arteries the option of less invasive surgery to repair their potentially life-threatening abdominal aortic aneurysm.
Jack Kory of Mokena, Il. was eating his breakfast oatmeal when he suddenly felt the worst pain in his life. The searing pain came on suddenly in his stomach and spread to his knees. It was caused by an abdominal aortic aneurysm (AAA) that had suddenly burst, causing massive internal bleeding. Traditionally, few patients have survived such ruptures. But Loyola University Medical Center vascular surgeon Dr. Richard Hershberger was able to repair Kory's aneurysm with a minimally invasive emergency procedure.
The Methodist Hospital has been chosen as a study site for a new type of stent graft device that is designed for the repair of certain types of aortic aneurysms near or involving the blood vessels that lead to the kidneys. The Ventana Fenestrated Stent Graft System is made by Endologix Inc., which is sponsoring both the feasibility and pivotal studies of the device.
Richard Holbrooke, John Ritter, Lucille Ball, Jonathan Larson and Great Britain's King George II were all taken by the same silent killer: an acute aortic dissection. Now, scientists led by researchers at The University of Texas Health Science Center at Houston and Baylor College of Medicine have found an association with a common genetic variant in the population that predisposes people to acute dissections and can approximately double a person's chances of having the disease.
Are you scheduled for heart bypass surgery or weight loss surgery? You might want to find out just how frequently different hospitals in your area are performing those procedures before deciding where to go. A new study finds that hospitals with higher surgical volumes for certain procedures are less likely to cause unintentional serious injuries to hospitalized patients when compared to those hospitals that perform the procedures less often.
The cholesterol-lowering drug simvastatin appears to reduce spinal cord injury caused by oxygen deprivation in experimental animals, according to a study in the September issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
New data in the July 2011 issue of the Journal of Vascular Surgery, the official publication of the Society for Vascular Surgery, compares the effects of gender on long-term survival in different types of abdominal aortic aneurysm (AAA) repair.
A free public lecture by a University of Leicester academic on Tuesday, 28 June will discuss recent advances to reduce mortality from aortic aneurysms.
An innovative medical device used in the minimally invasive treatment of thoracic aortic aneurysms, the Valiant Thoracic Stent Graft System from Medtronic, Inc., delivered excellent clinical results through one year of patient follow-up in the company's U.S. pivotal study, VALOR II, according to data presented today at a meeting for vascular surgeons.
When Dr. Ross Milner repaired Lydia Strebing's life-threatening abdominal aortic aneurysm, she was astonished at how easy it was. "I've had more pain from dental procedures," she said. "This was nothing." Milner, chief of vascular surgery at Loyola University Hospital, repaired the bulging aneurysm by using a catheter to deploy a device called a stent graft.
Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced CE Mark approval for the Aptus EndoStapling System. The innovative helical staple technology enables independent endograft fixation, and is designed to mimic the hand suturing performed during open surgical repair of abdominal aortic aneurysms.
Scott & White Healthcare today teleconferenced one of the world's first live international surgical procedures to repair an abdominal aortic aneurysm to conference attendees in Sao Paolo, Brazil. The meeting, CICE (Current Issues in Comparative Education) 2011, is one of the globe's largest vascular surgery events and includes over 2,000 attendees. The procedure demonstrated the use of an endograft device called a repositionable endoprosthesis.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.